VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
21 02 2020
Historique:
received: 30 09 2019
accepted: 11 12 2019
pubmed: 25 12 2019
medline: 22 12 2020
entrez: 25 12 2019
Statut: epublish

Résumé

As shifts in the epidemiology of β-lactamase-mediated resistance continue, carbapenem-resistant

Identifiants

pubmed: 31871094
pii: AAC.01963-19
doi: 10.1128/AAC.01963-19
pmc: PMC7038240
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Borinic Acids 0
Carboxylic Acids 0
beta-Lactamase Inhibitors 0
Cefepime 807PW4VQE3
taniborbactam 8IGQ156Z07

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 101999/Z/13/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI089512
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201300019C
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : HHSN272201300019I
Pays : United States

Informations de copyright

Copyright © 2020 Hamrick et al.

Références

Nat Rev Microbiol. 2019 May;17(5):295-306
pubmed: 30837684
Antimicrob Agents Chemother. 2010 Aug;54(8):3197-204
pubmed: 20498317
Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55
pubmed: 26248364
Diagn Microbiol Infect Dis. 2013 Feb;75(2):115-20
pubmed: 23290507
EBioMedicine. 2017 May;19:98-106
pubmed: 28479289
Emerg Infect Dis. 2019 Jun;25(6):1209-1213
pubmed: 31107227
J Med Chem. 2015 May 14;58(9):3682-92
pubmed: 25782055
ACS Infect Dis. 2018 Feb 9;4(2):84-87
pubmed: 29232103
Nat Rev Drug Discov. 2015 Jul;14(7):445-7
pubmed: 26129790
Antimicrob Agents Chemother. 2019 Sep 16;:
pubmed: 31527031
J Infect Chemother. 2018 Nov;24(11):915-920
pubmed: 30197092
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28115348
J Enzyme Inhib Med Chem. 2017 Dec;32(1):917-919
pubmed: 28719998
Drugs. 2018 Apr;78(6):675-692
pubmed: 29671219
S D Med. 2019 Mar;72(3):136-138
pubmed: 31018063
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14280-5
pubmed: 11724923
Trends Pharmacol Sci. 2018 Jul;39(7):635-647
pubmed: 29680579
Antimicrob Agents Chemother. 2014 May;58(5):2740-6
pubmed: 24566187
Int J Infect Dis. 2019 Aug;85:203-211
pubmed: 31229615
J Med Chem. 2019 Dec 16;:
pubmed: 31765155
Antimicrob Agents Chemother. 2013 Jun;57(6):2496-505
pubmed: 23439634
BMC Microbiol. 2017 Apr 27;17(1):101
pubmed: 28449650
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1297-1300
pubmed: 31474240
Drug Resist Updat. 2016 Nov;29:30-46
pubmed: 27912842
Acta Pharm Sin B. 2016 Nov;6(6):552-556
pubmed: 27818921
Antimicrob Agents Chemother. 2015 Dec 07;60(2):1067-78
pubmed: 26643349
Ann Pharmacother. 2007 Nov;41(11):1859-66
pubmed: 17911203
J Mol Biol. 2008 Jan 18;375(3):604-11
pubmed: 18061205
J Antimicrob Chemother. 2013 Aug;68(8):1825-31
pubmed: 23580564
J Antimicrob Chemother. 2017 May 1;72(5):1340-1349
pubmed: 28199647
Int J Antimicrob Agents. 2015 Nov;46(5):483-93
pubmed: 26498989
J Glob Infect Dis. 2016 Jan-Mar;8(1):41-50
pubmed: 27013843
J Glob Antimicrob Resist. 2019 Dec;19:28-31
pubmed: 30825700
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):386-94
pubmed: 21460457
J Antimicrob Chemother. 2018 Mar 1;73(3):658-663
pubmed: 29149337
Nat Commun. 2016 Aug 08;7:12406
pubmed: 27499424
Antimicrob Agents Chemother. 2009 Nov;53(11):4783-8
pubmed: 19738025
Antimicrob Agents Chemother. 2001 Mar;45(3):660-3
pubmed: 11181339
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
ACS Infect Dis. 2019 Jan 11;5(1):9-34
pubmed: 30421910
J Biol Chem. 2013 Sep 27;288(39):27960-71
pubmed: 23913691
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28031201
Lancet Infect Dis. 2013 Oct;13(10):867-76
pubmed: 23845533
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30061284
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28223379
Infect Dis Clin North Am. 2016 Jun;30(2):441-464
pubmed: 27208767
Antimicrob Agents Chemother. 1999 Apr;43(4):902-6
pubmed: 10103197
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Diagn Microbiol Infect Dis. 2017 Dec;89(4):305-309
pubmed: 28969934
Open Forum Infect Dis. 2015 May 05;2(2):ofv050
pubmed: 26125030

Auteurs

Jodie C Hamrick (JC)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Jean-Denis Docquier (JD)

Department of Medical Biotechnology, University of Siena, Siena, Italy.

Tsuyoshi Uehara (T)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Cullen L Myers (CL)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

David A Six (DA)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Cassandra L Chatwin (CL)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Kaitlyn J John (KJ)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Salvador F Vernacchio (SF)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Susan M Cusick (SM)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Robert E L Trout (REL)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Cecilia Pozzi (C)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Filomena De Luca (F)

Department of Medical Biotechnology, University of Siena, Siena, Italy.

Manuela Benvenuti (M)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Stefano Mangani (S)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Bin Liu (B)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Randy W Jackson (RW)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Greg Moeck (G)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Luigi Xerri (L)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Christopher J Burns (CJ)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Daniel C Pevear (DC)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA.

Denis M Daigle (DM)

Venatorx Pharmaceuticals Incorporated, Malvern, Pennsylvania, USA daigle@venatorx.com.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH